What is LOPJLB’s current signal on NVO?

LOPJLB’s latest quantitative signal on Novo Nordisk A/S (NVO) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is NVO in?

Novo Nordisk A/S (NVO) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Novo Nordisk A/S (NVO) do?

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two …

Where is Novo Nordisk A/S based / listed?

Novo Nordisk A/S is based in DK, listed on NYSE.

Novo Nordisk A/S (NVO)

Healthcare · Drug Manufacturers - General · NYSE · DK

$46.92+0.39%Close

SELLRECOVERY · day 12

[SCORES & PROFILE]

FUND: 46
VALUE: 50
GROWTH: 63
GARP: 16
TYPE: Value / Recovery

Composite of Value · Growth · GARP

ROIC35.5%

REV YoY-

ROE59.1%

EPS YoY-

ROA19.6%

GROSS

NET

[VALUATION]

P/E TTM11.41

P/E FWD-

SECTOR PE22.66

INDUSTRY PE11.13

P/B5.99

P/FCF-

EV/EBITDA8.24

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E63.33

ALTMAN Z-

CURR RATIO0.87

ND/EBITDA-

BETA0.35

Novo Nordisk A/S (NVO)

Key stats

Sector peers

Industry peers

Prediction markets

FUNDAMENTALS

Company news